1. Home
  2. TFII vs BIO Comparison

TFII vs BIO Comparison

Compare TFII & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFI International Inc.

TFII

TFI International Inc.

HOLD

Current Price

$133.78

Market Cap

8.1B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$256.06

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFII
BIO
Founded
1957
1952
Country
Canada
United States
Employees
N/A
7450
Industry
Trucking Freight/Courier Services
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
7.1B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
TFII
BIO
Price
$133.78
$256.06
Analyst Decision
Buy
Buy
Analyst Count
12
4
Target Price
$146.50
$339.75
AVG Volume (30 Days)
348.4K
284.7K
Earning Date
04-27-2026
04-30-2026
Dividend Yield
1.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.16
$2.74
Revenue Next Year
$4.68
$3.20
P/E Ratio
$31.26
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$80.27
$211.43
52 Week High
$149.09
$343.12

Technical Indicators

Market Signals
Indicator
TFII
BIO
Relative Strength Index (RSI) 56.79 34.62
Support Level $84.30 $246.01
Resistance Level N/A $289.61
Average True Range (ATR) 4.20 10.58
MACD -0.02 -4.56
Stochastic Oscillator 42.96 18.56

Price Performance

Historical Comparison
TFII
BIO

About TFII TFI International Inc.

TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customer's specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: